With an increasing understanding of the cellular and molecular mechanisms underpinning CRC, apoptotic pathways, specifically the targeting of antiapoptotic proteins such as Bcl‐2 and Survivin, have garnered immense attention in therapeutic research.8, 9. Here, BCL2 is linked to colorectal carcinoma.